{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:27:07Z","timestamp":1788830827247,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118483","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:32:55Z","timestamp":1765989175000},"page":"118483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combinatorial library design approach identifies a novel benzothiazole-based hexokinase 2 inhibitor with anti-tumor efficacy in oral squamous cell carcinoma"],"prefix":"10.1016","volume":"304","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8327-9200","authenticated-orcid":false,"given":"Purbali","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouvik","family":"Bhuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda","family":"Lubna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashna","family":"Fathima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Deepika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pruthvi","family":"Gudipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8604-7886","authenticated-orcid":false,"given":"Manab","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinath","family":"Jamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6075-4029","authenticated-orcid":false,"given":"Perumal","family":"Yogeeswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118483_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02984629","article-title":"Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging","volume":"19","author":"Tian","year":"2005","journal-title":"Ann. Nucl. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib2","article-title":"A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118483_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fonc.2020.00176","article-title":"Regulatory role of hexokinase 2 in modulating head and neck tumorigenesis","volume":"10","author":"Li","year":"2020","journal-title":"Frontiers in oncology"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100077","article-title":"Hexokinases in cancer and other pathologies","volume":"2","author":"Guo","year":"2023","journal-title":"Cell Insight"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118483_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118483_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012228118","article-title":"Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients","volume":"118","author":"Yang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118483_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.118483_bib9","series-title":"Hexokinase 2 in Colorectal Cancer: a Potent Prognostic Factor Associated with Glycolysis, Proliferation and Migration","author":"Katagiri","year":"2017"},{"issue":"34","key":"10.1016\/j.ejmech.2025.118483_bib10","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9760","article-title":"Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer","volume":"8","author":"Anderson","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118483_bib11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J. Exp. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118483_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/cdd.2014.173","article-title":"Hexokinase II integrates energy metabolism and cellular protection: akting on mitochondria and TORCing to autophagy","volume":"22","author":"Roberts","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.118483_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbpa.2017.03.017","article-title":"Combinatorial chemistry in drug discovery","volume":"38","author":"Liu","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118483_bib14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/acs.jmedchem.1c00963","article-title":"Small molecule kinase inhibitor drugs (1995\u20132021): medical indication, pharmacology, and synthesis","volume":"65","author":"Ayala-Aguilera","year":"2021","journal-title":"J. Med. Chem."},{"issue":"7958","key":"10.1016\/j.ejmech.2025.118483_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/acs.jcim.9b00841","article-title":"In silico design and analysis of a kinase-focused combinatorial library considering diversity and quality","volume":"60","author":"Yang","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118483_bib17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/acs.jmedchem.2c01886","article-title":"Discovery of highly potent and BMPR2-selective kinase inhibitors using DNA-encoded chemical library screening","volume":"66","author":"Modukuri","year":"2023","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118483_bib18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jcim.6b00122","article-title":"Unprecedently large-scale kinase inhibitor set enabling the accurate prediction of compound\u2013kinase activities: a way toward selective promiscuity by design?","volume":"56","author":"Christmann-Franck","year":"2016","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118483_bib19","first-page":"3413","article-title":"2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism","volume":"63","author":"Lin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118483_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118483_bib21","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1871520623666230406111833","article-title":"3-Bromopyruvate inhibits the growth and glucose metabolism of TNBC xenografts in nude mice by targeting c-Myc","volume":"23","author":"Pan","year":"2023","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118483_bib22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41417-023-00648-5","article-title":"3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis","volume":"30","author":"Mu","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejmech.2025.118483_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0530-4","article-title":"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2","volume":"36","author":"Li","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118483_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105367","article-title":"Novel selective hexokinase 2 inhibitor benitrobenrazide blocks cancer cells growth by targeting glycolysis","volume":"164","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118483_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acsmedchemlett.5b00214","article-title":"Discovery of a novel 2, 6-disubstituted glucosamine series of potent and selective hexokinase 2 inhibitors","volume":"7","author":"Lin","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118483_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.109264","article-title":"A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2","volume":"35","author":"Liu","year":"2024","journal-title":"Chin. Chem. Lett."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118483_bib27","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1021\/acs.jmedchem.3c00118","article-title":"Degradation of hexokinase 2 blocks glycolysis and induces gsdme-dependent pyroptosis to amplify immunogenic cell death for breast cancer therapy","volume":"66","author":"Sang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118483_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4155\/fmc-2021-0205","article-title":"Combining structure-based and 3D QSAR pharmacophore models to discover diverse ligands against EGFR in oral cancer","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118483_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1346270","article-title":"Targeting hexokinase 2 for oral cancer therapy: structure-based design and validation of lead compounds","volume":"15","author":"Chakraborty","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41420-024-02226-6","article-title":"Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118483_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41419-019-1965-7","article-title":"Dissociation of mitochondrial HK-II elicits mitophagy and confers cardioprotection against ischemia","volume":"10","author":"Tan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118483_bib32","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1111\/jcmm.14971","article-title":"Novel mitochondrion\u2010targeting copper (II) complex induces HK2 malfunction and inhibits glycolysis via Drp1\u2010mediating mitophagy in HCC","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171666","article-title":"The catalytic inactivation of the N-half of human hexokinase 2 and structural and biochemical characterization of its mitochondrial conformation","volume":"38","author":"Nawaz","year":"2018","journal-title":"Biosci. Rep"},{"issue":"20","key":"10.1016\/j.ejmech.2025.118483_bib34","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1039\/c3cp00116d","article-title":"Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations","volume":"15","author":"Godschalk","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118483_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-010-0884-1","article-title":"Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines","volume":"126","author":"Millon","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118483_bib36","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1002\/cam4.2463","article-title":"Hexokinase 2 dimerization and interaction with voltage\u2010dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer","volume":"8","author":"Fan","year":"2019","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118483_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbabio.2009.03.003","article-title":"Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate","volume":"1787","author":"Chen","year":"2009","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118483_bib38","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190880","article-title":"Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin","volume":"39","author":"Rai","year":"2019","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118483_bib39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.stemcr.2021.03.030","article-title":"The role of SQSTM1 (p62) in mitochondrial function and clearance in human cortical neurons","volume":"16","author":"Poon","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118483_bib40","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.4161\/auto.32177","article-title":"Choline dehydrogenase interacts with SQSTM1\/p62 to recruit LC3 and stimulate mitophagy","volume":"10","author":"Park","year":"2014","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/0008-5472.CAN-13-2037","article-title":"VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells","volume":"75","author":"Curtarello","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/biom11010085","article-title":"Vascular endothelial growth factor: a translational view in oral non-communicable diseases","volume":"11","author":"Niklander","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118483_bib43","article-title":"Genetic evidence that uptake of the fluorescent analog 2NBDG occurs independently of known glucose transporters","volume":"17","author":"D'Souza","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118483_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0633-y","article-title":"Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts","volume":"36","author":"Fan","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/jomfp.JOMFP_334_19","article-title":"Epithelial\u2013mesenchymal transition in oral squamous cell carcinoma: an insight into molecular mechanisms and clinical implications","volume":"24","author":"Jayanthi","year":"2020","journal-title":"J. Oral Maxillofac. Pathol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118483_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jobcr.2023.05.001","article-title":"Cadherin switching in oral squamous cell carcinoma: a clinicopathological study","volume":"13","author":"Ali","year":"2023","journal-title":"J. Oral Biol. Craniofac. Res."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118483_bib48","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118483_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/molecules28010044","article-title":"Docking and molecular dynamic investigations of phenylspirodrimanes as cannabinoid receptor-2 agonists","volume":"28","author":"Omar","year":"2022","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:50:33Z","timestamp":1771465833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S0223523425012486"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118483","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial library design approach identifies a novel benzothiazole-based hexokinase 2 inhibitor with anti-tumor efficacy in oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118483"}}